Health Care System
On March 6, House Republican leaders unveiled a legislative package to repeal and replace parts of the Affordable Care Act (ACA).
Every day, we see stories about the exorbitant costs of prescription drugs and the serious challenges they pose for individuals and the entire health care system.
One program that has a 25-year track record of improving access to medications and health care services for people in vulnerable…
The Health Resources and Services Administration today delayed, in accordance with a recent White House memorandum, the effective date of its final rule on drug ceiling prices and civil monetary penalties for
This report identifies the practical barriers to achieving the goals of a value-based payment system created by current laws and recommends specific legislative changes.
There is a critical need to elevate the discussion around workforce planning and development to ensure that it becomes a standing component of comprehensive strategic planning for hospitals and health systems, and not just a response to a crisis situation.
The AHA and Federation of ºÚÁÏÕýÄÜÁ¿s today expressed strong opposition to the Patient Access to Higher Quality Health Care Act (H.R. 1156), and any other legislation that would repeal or modify current law to expand self-referral to physician-owned hospitals.
Today, draft legislative language became public regarding potential Affordable Care Act (ACA) repeal and replace legislation that may be considered by the House. This Bulletin summarizes major parts of the bill.
A new AHA infographic highlights the benefits of hospital mergers, as revealed by a recent study by Charles River Associates.
What are vulnerable communities? They’re communities in rural and inner-city America that lack access to primary care or are hobbled by a poor economy, high rates of uninsured and low health literacy, among other things.
For the millions of Americans who live in them, the local hospital is an…
The administration yesterday withdrew the Health Resources and Services Administration’s pending omnibus guidance for the 340B Drug Pricing Program. “We are pleased that the Administration chose not to finalize the Health Resources and Services Administration’s guidance, which, if enacted…